Matches in Nanopublications for { ?s ?p "[Overall, c-met protein staining was noted in 36 of 43 (84%) primary prostate cancer samples versus 2 of 11 (18%) benign prostate hyperplasia samples (p < 0.0001) and in 4 of 4 (100%) lymph node metastases, 23 of 23 (100%) bone marrow metastases and 1 of 3 (33%) other metastatic sites.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 9 of
9
with 100 items per page.
- NP554331.RAaC5yCxZiBZKluXDB2opDOn1SGGFZHuYVchPrY60a2ck130_assertion description "[Overall, c-met protein staining was noted in 36 of 43 (84%) primary prostate cancer samples versus 2 of 11 (18%) benign prostate hyperplasia samples (p < 0.0001) and in 4 of 4 (100%) lymph node metastases, 23 of 23 (100%) bone marrow metastases and 1 of 3 (33%) other metastatic sites.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP554331.RAaC5yCxZiBZKluXDB2opDOn1SGGFZHuYVchPrY60a2ck130_provenance.
- assertion description "[Overall, c-met protein staining was noted in 36 of 43 (84%) primary prostate cancer samples versus 2 of 11 (18%) benign prostate hyperplasia samples (p < 0.0001) and in 4 of 4 (100%) lymph node metastases, 23 of 23 (100%) bone marrow metastases and 1 of 3 (33%) other metastatic sites.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[Overall, c-met protein staining was noted in 36 of 43 (84%) primary prostate cancer samples versus 2 of 11 (18%) benign prostate hyperplasia samples (p < 0.0001) and in 4 of 4 (100%) lymph node metastases, 23 of 23 (100%) bone marrow metastases and 1 of 3 (33%) other metastatic sites.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[Overall, c-met protein staining was noted in 36 of 43 (84%) primary prostate cancer samples versus 2 of 11 (18%) benign prostate hyperplasia samples (p < 0.0001) and in 4 of 4 (100%) lymph node metastases, 23 of 23 (100%) bone marrow metastases and 1 of 3 (33%) other metastatic sites.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[Overall, c-met protein staining was noted in 36 of 43 (84%) primary prostate cancer samples versus 2 of 11 (18%) benign prostate hyperplasia samples (p < 0.0001) and in 4 of 4 (100%) lymph node metastases, 23 of 23 (100%) bone marrow metastases and 1 of 3 (33%) other metastatic sites.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP1311517.RAYm5k3t7FsZp7WI5itRixqRWVCl91aQV5Q4HLdXf1R3U130_assertion description "[Overall, c-met protein staining was noted in 36 of 43 (84%) primary prostate cancer samples versus 2 of 11 (18%) benign prostate hyperplasia samples (p < 0.0001) and in 4 of 4 (100%) lymph node metastases, 23 of 23 (100%) bone marrow metastases and 1 of 3 (33%) other metastatic sites.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1311517.RAYm5k3t7FsZp7WI5itRixqRWVCl91aQV5Q4HLdXf1R3U130_provenance.
- NP554368.RArSM_5pcHSB4lccsW3KneR4oSP5cAg-kFmhaUp79ERc0130_assertion description "[Overall, c-met protein staining was noted in 36 of 43 (84%) primary prostate cancer samples versus 2 of 11 (18%) benign prostate hyperplasia samples (p < 0.0001) and in 4 of 4 (100%) lymph node metastases, 23 of 23 (100%) bone marrow metastases and 1 of 3 (33%) other metastatic sites.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP554368.RArSM_5pcHSB4lccsW3KneR4oSP5cAg-kFmhaUp79ERc0130_provenance.
- NP1311518.RApUL0tlcCBsssbt-pr7tTT1xHjcRU8tV_oMBYGkC7RNQ130_assertion description "[Overall, c-met protein staining was noted in 36 of 43 (84%) primary prostate cancer samples versus 2 of 11 (18%) benign prostate hyperplasia samples (p < 0.0001) and in 4 of 4 (100%) lymph node metastases, 23 of 23 (100%) bone marrow metastases and 1 of 3 (33%) other metastatic sites.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1311518.RApUL0tlcCBsssbt-pr7tTT1xHjcRU8tV_oMBYGkC7RNQ130_provenance.
- NP1311514.RA3CHrsAfS7_tkhcDbaKUddOHcSGmXgi-jjwJEEsh2xts130_assertion description "[Overall, c-met protein staining was noted in 36 of 43 (84%) primary prostate cancer samples versus 2 of 11 (18%) benign prostate hyperplasia samples (p < 0.0001) and in 4 of 4 (100%) lymph node metastases, 23 of 23 (100%) bone marrow metastases and 1 of 3 (33%) other metastatic sites.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1311514.RA3CHrsAfS7_tkhcDbaKUddOHcSGmXgi-jjwJEEsh2xts130_provenance.